Bayer AG (BAYRY)
5.41
+0.05
(+0.93%)
USD |
OTCM |
Nov 14, 15:59
Bayer Revenue (Quarterly): 12.00B for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 12.00B |
| March 31, 2024 | 14.95B |
| December 31, 2023 | 12.77B |
| September 30, 2023 | 11.26B |
| June 30, 2023 | 12.04B |
| March 31, 2023 | 15.45B |
| December 31, 2022 | 12.27B |
| September 30, 2022 | 11.36B |
| June 30, 2022 | 13.65B |
| March 31, 2022 | 16.43B |
| December 31, 2021 | 12.72B |
| September 30, 2021 | 11.53B |
| June 30, 2021 | 13.08B |
| March 31, 2021 | 14.86B |
| December 31, 2020 | 11.92B |
| September 30, 2020 | 9.947B |
| June 30, 2020 | 11.07B |
| March 31, 2020 | 14.18B |
| December 31, 2019 | 11.90B |
| September 30, 2019 | 10.93B |
| June 30, 2019 | 12.03B |
| March 31, 2019 | 13.92B |
| December 31, 2018 | 11.81B |
| September 30, 2018 | 10.77B |
| June 30, 2018 | 11.32B |
| Date | Value |
|---|---|
| March 31, 2018 | 11.23B |
| December 31, 2017 | 10.12B |
| September 30, 2017 | 9.434B |
| June 30, 2017 | 9.588B |
| March 31, 2017 | 10.31B |
| December 31, 2016 | 9.518B |
| September 30, 2016 | 9.217B |
| June 30, 2016 | 13.37B |
| March 31, 2016 | 13.08B |
| December 31, 2015 | 12.35B |
| September 30, 2015 | 12.23B |
| June 30, 2015 | 13.26B |
| March 31, 2015 | 13.40B |
| December 31, 2014 | 13.48B |
| September 30, 2014 | 13.21B |
| June 30, 2014 | 14.03B |
| March 31, 2014 | 14.46B |
| December 31, 2013 | 13.46B |
| September 30, 2013 | 12.78B |
| June 30, 2013 | 13.53B |
| March 31, 2013 | 13.55B |
| December 31, 2012 | 12.79B |
| September 30, 2012 | 12.08B |
| June 30, 2012 | 13.05B |
| March 31, 2012 | 13.18B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
9.947B
Minimum
Sep 2020
16.43B
Maximum
Mar 2022
12.81B
Average
12.27B
Median
Dec 2022
Revenue (Quarterly) Benchmarks
| CureVac NV | 15.54M |
| Affimed NV | 0.1658M |
| InflaRx NV | 0.1362M |
| BioNTech SE | 1.369B |
| Immatics NV | 20.19M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.61M |
| Total Expenses (Quarterly) | 11.43B |
| EPS Diluted (Quarterly) | -0.0081 |
| Enterprise Value | 10.49B |
| Gross Profit Margin (Quarterly) | 55.19% |
| Profit Margin (Quarterly) | -0.31% |
| Earnings Yield | -6.54% |
| Operating Earnings Yield | 48.75% |
| Normalized Earnings Yield | -6.538 |